This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update,” Hatcher-Martin et al. review the literature on telemedicine for concussion, dementia, epilepsy, headache, movement, multiple sclerosis, neuromuscular, and inpatient neurology consults. The authors conclude that telemedicine expedites care, increases access, reduces cost, and improves diagnostic accuracy and health outcomes, but that further studies are needed to understand the role for telemedicine in neurology. Devanathan notes that telemedicine has successfully been used in India to provide guidance for clinicians and patients in distant parts of the country about a range of neurologic conditions. Similarly, Mao et al. describe the positive impact of teleneuroimmunology in China. However, both Devanathan and Mao et al. caution that establishment of guidelines about telemedicine is imperative to optimize care and prevent litigation. Since the publication of this article, the COVID-19 pandemic has precipitated the rapid incorporation of telemedicine into every specialty of neurology in countries around the world, and we have gained better insight to the advantages and disadvantages of virtual visits. We anticipate that widespread adoption of teleneurology will spur further investigation and innovation provided that it continues to be supported by insurance companies.
In “Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update,” Hatcher-Martin et al. review the literature on telemedicine for concussion, dementia, epilepsy, headache, movement, multiple sclerosis, neuromuscular, and inpatient neurology consults. The authors conclude that telemedicine expedites care, increases access, reduces cost, and improves diagnostic accuracy and health outcomes, but that further studies are needed to understand the role for telemedicine in neurology. Devanathan notes that telemedicine has successfully been used in India to provide guidance for clinicians and patients in distant parts of the country about a range of neurologic conditions. Similarly, Mao et al. describe the positive impact of teleneuroimmunology in China. However, both Devanathan and Mao et al. caution that establishment of guidelines about telemedicine is imperative to optimize care and prevent litigation. Since the publication of this article, the COVID-19 pandemic has precipitated the rapid incorporation of telemedicine into every specialty of neurology in countries around the world, and we have gained better insight to the advantages and disadvantages of virtual visits. We anticipate that widespread adoption of teleneurology will spur further investigation and innovation provided that it continues to be supported by insurance companies.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
